STING1 and cancer: Hence, dysregulation of these regulatory mechanisms leads to aberrant activation of the cGAS–STING pathway, which induces exaggerated immune responses that lead to sterile inflammatory conditions, including cardiometabolic disorders, neurodegenerative diseases, autoimmune diseases and cancers.